3 global pharma giants, NUS and A*Star team up for manufacturing innovation
[SINGAPORE] Pharmaceutical manufacturing in Singapore is set to benefit from industry partnerships, with Minister for Trade and Industry (Industry) S Iswaran announcing the launch on Tuesday of the Pharma Innovation Programme Singapore.
The industry development scheme is a tie-up between the National University of Singapore, the Agency for Science, Technology and Research (A*Star) and three global drug giants - GlaxoSmithKline, Pfizer and MSD.
It will focus on areas such as continuous manufacturing, bio-catalysis, process analytical technology and advanced process control.
Full Story Here.
BT is now on Telegram!
For daily updates on weekdays and specially selected content for the weekend. Subscribe to t.me/BizTimes
Consumer & Healthcare
Nestle sales growth sputters on US slump, vitamin snags
Hermes Q1 sales jump 17% on strong China demand
Cordlife’s independent auditor to retire after issuing disclaimer of opinion on FY2023 financials
Cutting the cord?: Events leading up to Cordlife’s MOH suspension and arrests of its directors, ex-group CEO
Cordlife customers push for legal action
France's Casino supermarket chain to axe up to 3,200 jobs